Chemotherapy Toxicity Risk Score Use Improved Treatment Choice for Elderly

Share this content:
Among patients reviewed, 88% of patients with CTRS 10 or greater had a significantly higher rate of toxicity compared with patients with a CRTS below 10.
Among patients reviewed, 88% of patients with CTRS 10 or greater had a significantly higher rate of toxicity compared with patients with a CRTS below 10.

Elderly patients with advanced cancer who have a high chemotherapy toxicity risk score (CTRS) may experience significant toxicity and increased rates of hospitalization when treated with combination chemotherapy, according to a study published in The Oncologist.

The current criteria determining anticancer therapy for elderly patients — such as physician's evaluation of fitness, geriatric assessment (GA) — often fails to take into consideration the entire clinical picture, leading to difficulties in choosing standard therapy (ST) or reduced therapy (RT) for this patient population.

For this prospective observational study, researchers enrolled 58 elderly patients with advanced cancer scheduled to receive first-line combination chemotherapy. Patients were categorized into 2 groups: high risk patients with a CTRS 10 or greater for whom reduced dose combination or single-agent chemotherapy was the appropriate treatment choice, and patients with a CTRS lower than 10 for whom standard-dose therapy was appropriate.

Of the 38 patients who received ST, 21 had a CTRS less than 10 and 17 patients had a CTRS 10 or greater; and of the 20 patients who received RT, 12 had a CTRS 10 or greater and 8 had a CTRS less than 10.

Among patients in the ST group, 88% of patients with CTRS 10 or greater had a significantly higher rate of toxicity compared with 40% of patients with a CRTS less than 10 (P =.006). Patients with a high CTRS score also had higher rates of hospitalization vs patients with low CTRS scores (50% vs 15%; P =.03).

The authors concluded that “as quality of life, functional status, and survival are also important outcomes for older adults with cancer, further studies are warranted to evaluate how incorporation of the CTRS in treatment decisions affects these outcomes.”

Reference

Nishijima TF, Deal AM, Williams GR, et al. Chemotherapy toxicity risk score for treatment decisions in older adults with advanced solid tumors [published online January 25, 2018]. Oncologist. doi: 10.1634/theoncologist.2017-0559

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs